101 results
Page 5 of 6
8-K
qqjd41
23 Oct 19
Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTACĀ® Targeted Protein Degraders
6:39am
424B3
5rz dcof2zvc8raau
18 Oct 19
Prospectus supplement
5:05pm
424B3
gz52w7l13hej8k5n
11 Oct 19
Prospectus supplement
7:44am
S-3
xota 2xbrzjp50a
1 Oct 19
Shelf registration
6:37pm
8-K
EX-99.1
bo1vzn
5 Aug 19
Arvinas Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:05pm
8-K
EX-99.1
7rzo2l0hd
8 May 19
Arvinas Reports First Quarter Financial Results and Provides Corporate Update
5:27pm
8-K
EX-99.1
z7q0lm1
1 Apr 19
Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
4:52pm
10-K
spqm3
26 Mar 19
Annual report
4:31pm
10-Q
sjwii tu2xlopbade
14 Nov 18
Quarterly report
12:00am
8-K
EX-3.2
0xifjlp11 bgh9vsk9k
1 Oct 18
Amendments to Articles of Incorporation or Bylaws
4:02pm
DRS/A
EX-4.3
s6n84822nn reiw1o
2 Aug 18
Draft registration statement (amended)
12:00am
DRS/A
vf1dmaycwmo5cy5
2 Aug 18
Draft registration statement (amended)
12:00am
DRS
gsx70zax
22 Jun 18
Draft registration statement
12:00am
DRS
EX-10.6
39t8sogqgmx
22 Jun 18
Draft registration statement
12:00am